指南与共识腹部技术与安全CTMR

基于2018年ASCO指南的转移性胰腺癌全身治疗及其相关毒性的影像学综述:每位放射科医生都应了解的内容

An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know.
指南 / 共识 · Abdom Radiol (NY) · 2019-01-01

本综述面向放射科医生,概述转移性胰腺癌现代全身治疗药物的影像学相关特征,内容依据美国临床肿瘤学会(ASCO)2018年更新的转移性胰腺癌治疗指南。文章强调理解这些药物的影像学意义对治疗反应评估和毒性评估至关重要,而全身治疗的诊断重要性在影像学文献中常被低估。

要点

  • 转移性胰腺癌一线和二线全身治疗药物不断增多,放射科医生需了解其影像学相关特征以评估治疗反应和毒性。
  • 本综述以ASCO 2018年转移性胰腺癌治疗指南为框架,提供放射科医生应知的现代全身治疗药物影像学要点。
  • 理解现代全身治疗药物的影像学意义对诊断影像解读至关重要,尤其涉及治疗反应和毒性评估。

核心结论

  • 了解转移性胰腺癌现代全身治疗及其相关毒性特征,对诊断影像解读至关重要。

研究设计与样本

  • 综述性文章,以ASCO 2018年更新的转移性胰腺癌治疗指南为框架,概述现代全身治疗药物的影像学相关特征;原文未报告检索范围与纳入文献数量。

临床应用与阅片要点

  • 放射科医生应了解转移性胰腺癌现代全身治疗药物的影像学相关特征,以协助治疗反应和毒性评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To provide an overview of what radiologists should know about systemic agents utilized in the modern treatment of metastatic pancreatic cancer and their associated toxicities.

RESULTS: The clinical landscape of metastatic pancreatic cancer has significantly evolved in recent years, with the advent of new first- and second-line systemic therapies. As these systemic treatment options continue to expand, knowledge of their clinically relevant features is becoming critical for radiologists. While the issues of surgical resectability and tumor response evaluation of advanced stages of pancreatic cancer have been thoroughly discussed in the radiology literature, the diagnostic importance of systemic therapies has tended to be less well appreciated. In this review, we provide a primer for radiologists outlining the radiologically pertinent features of modern systemic therapies used in the treatment of metastatic pancreatic ductal adenocarcinoma. These systemic agents are discussed from the standpoint of the newly updated 2018 ( https://doi.org/10.1007/s00261-019-01954-z ) guidelines for the treatment of metastatic pancreatic cancer from the American Society of Clinical Oncology (ASCO). Understanding the radiology relevance of these modern therapeutic agents is critical, especially with regard to treatment response and toxicity assessment.

CONCLUSION: Knowledge of the modern systemic therapies utilized in the treatment of metastatic pancreatic cancer and their associated toxicity profiles is critical in diagnostic imaging interpretation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Smith DA, Somarouthu B, Ramaiya NH, et al. An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know. Abdom Radiol (NY). 2019. PMID: 30820626. doi:10.1007/s00261-019-01954-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。